Joyce Blaisdell
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Eicosanoids and Hypertension Pharmacology, Analytical Chemistry and Chromatography, Computational Drug Discovery Methods
Most-Cited Works
- → The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.(1994)952 cited
- → Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.(1994)750 cited
- → Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid(2001)497 cited
- → Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin(2001)236 cited
- → Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily(1991)209 cited
- → A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin(1998)199 cited
- → Gene structure ofCYP2C8 and extrahepatic distribution of the human CYP2Cs(1999)190 cited
- → Epidermal growth factor (EGF) stimulates EGF receptor synthesis.(1986)187 cited
- → Differences in the Incidence of the CYP2C19 Polymorphism Affecting the S-Mephenytoin Phenotype in Chinese Han and Bai Populations and Identification of a New Rare CYP2C19 Mutant Allele(1997)173 cited
- → Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele(1999)170 cited